BCL2 and gastric cancer: For example, in GC, SNHG3 facilitates the growth and spread of tumor cells by modulating the miRNA-139-5p/MYB signaling pathway [18], and SNHG6 is involved in cisplatin resistance and contributes to the progression of GC by modulating the miR-1297/BCL-2 signaling pathway [20].